Information:
Fel:
ID
34303
Beskrivning
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD); ODM derived from: https://clinicaltrials.gov/show/NCT01295710
Länk
https://clinicaltrials.gov/show/NCT01295710
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility GVHD NCT01295710
Eligibility GVHD NCT01295710
- StudyEvent: Eligibility
Similar models
Eligibility GVHD NCT01295710
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
boolean
ID.2
Item
patients with an unrelated hla-a,-b, -c and -drbi matched donor
boolean
ID.3
Item
patients with a karnofsky performance score ≥ 70%
boolean
ID.4
Item
key exclusion criteria:
boolean
ID.5
Item
clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
boolean
ID.6
Item
bacterial, viral, or fungal infections
boolean
ID.7
Item
known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
boolean
ID.8
Item
patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
boolean
ID.9
Item
known contraindications to the administration of rabbit immunoglobulin antibodies
boolean
ID.10
Item
hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
boolean